PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS
Steven M. Opal(Brown University), Noubar Kessimian(Memorial Hospital of Rhode Island), Abdullah Chahin(Miriam Hospital), Abdulrahman Chahin(Apple (Israel)), Nicholas Parejo(Memorial Hospital of Rhode Island), Vipin Suri, Yong Li(Second Affiliated Hospital of Xi'an Jiaotong University), John E. Palardy(Brown University), James L. Ellis(Tris Pharma (United States)), Michelle Yamamoto(Apple (Israel)), George P. Vlasuk(Unknown), Johannes Freudenberg(Cincinnati Children's Hospital Medical Center)
Cited by 50
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Intensive Care Medicine|2003|2.9k